Floatz logo

Acarbose

Cardiovascular Disease

Yale UniversitySmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

60 Active assets in the Cardiovascular Disease cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
AstraZeneca
Phase 4BBB
Lipitor
Duke University
Phase 4BBB
Liraglutide
University of Sao Paulo General Hospital
Phase 4BBB
Rosuvastatin
Nanjing First Hospital, Nanjing Medical University
Phase 4BBB
SIMVASTATIN
McMaster University
Phase 4BBB

View all 50 →

Same molecule, other indications

Acarbose is also rated in:

prediabetes syndromeDormant
BB
Indicative ·
66 / 100
View asset →
hypoglycemiaDormant
BB
Indicative ·
66 / 100
View asset →
coronary artery disorderDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →